Marti Law Group

We hope we'll see you at this upcoming dinner and discussion on selling a dental practice with Dental Practice Sales LLC. Justin T. Marti, Esq. draws from his personal experience selling a multi-location DSO to private equity. He joins Michael C. Wylie and Chris Hutzelman to discuss maximizing the value of your dental practice, the steps between an LOI and closing, and more.

We can't say it any better than Hannah Hembree did. We're so grateful to spend time among these inspiring women. (Hannah Hembree and Julia C. C., that includes you.)

Our team is counting down to Aesthetic Next by Aesthetic Record an EMR and Practice Management Solution. Will will see you there? Come meet Hannah Hembree at the booth, then check out Justin T. Marti, Esq. and Julia C. C. as they both present in this line-up of can’t-miss workshops and panels: Safeguarding Your Practice, Protecting Yourself as an Injector Hot Take: Legal Issues Impacting Aesthetics FDA Status on Semaglutide and Tirzepatide See you in Dallas!

Over the past few months, we’ve been covering the Federal Trade Commission’s (FTC) Non-Compete Clause Rule. The rule intended to ban non-compete agreements for most employees nationwide. In this newest update, however, Judge Ada Brown of the Northern District of Texas issued a broad order invalidating the final rule. As of August 20th, 2024, the noncompete ban is blocked. For employers and employees, this means noncompete agreements can continued to be upheld and issued. For more on this update and a timeline of events leading up to it, visit our blog: https://lnkd.in/gdesZ7hr

If there's one healthcare vertical we serve that is sure to catch our network's attention as their scrolling LinkedIn, it's the one with dogs on the graphic. 🐶 On this #nationaldogday, we're sharing veterinary trends for 2024 and celebrating all of the vets who provide care to our own furry family members!

Welcome to our newest team member, Savannah! Savannah is our Administrative and Operations Intern. She assists in client management and communication while helping our attorneys on case research, financial statements, and M&A deals for our clients. She shared that during her internship, she’s loved learning from her colleagues’ and clients’ experiences, shadowing work each day, and gaining valuable mentorship. And we love learning from her! She’s currently undergraduate student majoring in economics and mathematics while minoring in business at the University of Texas at Austin. Outside of work, she loves to hang out with friends, watch movies, and do yoga. We are lucky to have you, Savannah Rakowitz !!

Is your medical weight loss program compliant? Are GLP-1s still in shortage? What's happening with compounding? Join us LIVE on Instagram, tomorrow, August 20th, at 7:00 PM EST Everything You Need to Know About the GLP-1 Shortage Our team has spoken directly with representatives at the FDA regarding the semaglutide, tirzepatide, and the shortage list. Listen in as Justin T. Marti, Esq. and Julia C. C. break down everything we've learned about the current state of these weight loss drugs and what's ahead for Q4. To join, follow us on IG: @_martilawgroup Then, tune in at 7:00 PM EST, Tuesday, August 20th We hope to see you there!

🚨 Update! 🚨 The FDA provided our team with clearer guidance on the status of semaglutide and tirzepatide, confirming that these drugs remain “Currently in Shortage.” The increased availability of the drugs in their various presentations does not change the status of these drugs. If and when the FDA updates the shortage list status of these drugs to “Resolved,” then semaglutide and tirzepatide will be considered “commercially available drug products” which will restrict but not completely eliminate the production of compounded versions of the drugs. What does this mean for your practice? Be prepared! With this new clarity from the FDA, it’s the perfect time to reassess and fine-tune your approach to ensure full alignment with the latest regulations. This proactive adjustment will position your practice for continued success and compliance in the months ahead. Our team is continually seeking additional clarification from the FDA on how to move forward and plan for the possibility of the resolution of the weight loss drug shortage. We don’t have a crystal ball, but the increased availability of manufacturer drugs should be an impetus to put a plan in place for your practice. Stay tuned for more updates, and visit the full article on our blog to learn more. https://lnkd.in/gtPe_UmC

Your staff and providers keep your practice running and patients coming through the doors. As a practice owner, we know you’re eager to pay your people for a job well done. Of course, compensation structures aren’t always cut and dry at aesthetics practices. Thinking you may want to compensate referral sources or pay providers commissions? Not so fast. Navigating federal and state regulations regarding compensation compliance is essential to avoid legal pitfalls and penalties for your medical aesthetic practice. Our latest article provides an overview of these key issues and offers guidance for medical spa owners on how to remain compliant while compensating medical providers and staff. Our next article in this series gives a comparative analysis of some state laws that impact med spa compensation. Stay tuned! https://lnkd.in/gUHRcnnQ